Not all beneficial bacteria possess the ability to colonize well in the gut, therefore they cannot compete against harmful bacteria, which often possess an enhanced ability to adhere/colonize. If these beneficial microbes are not able to bind and colonize, they cannot activate their healing properties.

​

BioColonize™ refers to any beneficial bacteria, such as a probiotic, with the addition of specific genes that allow the bacteria to colonize more effectively in the gut. This platform contains genes that encode for a binding protein that was derived from a bacteria known for its ability to colonize well in the gut. This binding protein sticks to sugar molecules that are present on the epithelial cells that line the intestinal tract.

​

Using this platform of genes, we can take a personalized approach to medicine in which we can insert these genes into a bacteria that is suitable for the individual’s microbiome. A GEMM™ with this modification can then readily bind to the gut and activate healing mechanisms such as promoting mucosal healing and repairing the intestinal barrier.